Side effects, primarily nausea and gastrointestinal symptoms, were more common during dose escalation
[101] SIBO : SIBO (small intestinal bacterial overgrowth) is another potential Hashimotos root cause and contributor to constipation
Always patch-test before increasing the dosage or frequency to prevent irritation
3) Skyrizi (risankizumab) Skyrizi, a humanized monoclonal antibody, is the first specific IL-23 inhibitor indicated for the treatment of moderately to severely active Crohns disease in adults who have had inadequate response, lost response or were intolerant to conventional or biologic therapy
Note: While Mounjaro side effects are expected when beginning treatment and during each dose increase, titration can reduce this
Without monitoring, you could end up significantly overmedicated without realizing it